Page last updated: 2024-08-24

sertraline and Body Weight

sertraline has been researched along with Body Weight in 32 studies

Research

Studies (32)

TimeframeStudies, this research(%)All Research%
pre-19901 (3.13)18.7374
1990's8 (25.00)18.2507
2000's12 (37.50)29.6817
2010's8 (25.00)24.3611
2020's3 (9.38)2.80

Authors

AuthorsStudies
Acosta, A; Bielinski, SJ; Camilleri, M; Cifuentes, L; Decker, PA; Gonzalez-Izundegui, D; Hurtado, MD; Moyer, AM; Ricardo-Silgado, ML; Singh, S1
de Grava Kempinas, W; Figueiredo, TM; Franco de Barros, JW; Lozano, AFQ; Moura, MS; Tavares, BM; Valencise, L1
De Grava Kempinas, W; Dinhani, TRB; Lozano, AFQ; Moura, MS; Valencise, L1
Christensen, JP; Daldorph, E; Kromann, S; Kudirkiene, E; Li, L; Meng, H; Olsen, RH; Thoefner, I1
Alexopoulos, GS; Artis, AS; Banerjee, S; Bingham, KS; Flint, AJ; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM1
Barton, BA; Deligiannidis, KM; Flint, AJ; Kroll-Desrosiers, AR; Meyers, BS; Mulsant, BH; Rothschild, AJ; Whyte, EM1
Cai, H; Gong, H; Jiang, P; Li, H; Liu, Y; Tang, M; Zhang, L1
Adeniji, OS; Benmansour, S; Frazer, A; Privratsky, AA1
Appt, SE; Carr, JJ; Clarkson, TB; Jones, SR; Kritchevsky, SB; Register, TC; Shively, CA; Silverstein-Metzler, MG1
Terao, T1
Anthony, M; Davis, MF; Fankhauser, M; Freeman, MP; Fried, K; Moreno, F; Nolan, PE; Woosley, RL1
Kumar, A; Kumar, P1
Bonds, C; Davidson, MB; Duran, P; Echeverry, D; Lee, M1
Brambilla, F; Cioni, L; Company, M; Lovo, F; Mellado, C; Samek, L1
Beran, J; Jankovec, Z; Komorousova, J; Rusavy, Z1
Escudero, GE; Ferraresi Curotto, V; Ferrer, EG; Laino, CH; Pis Diez, R; Williams, PA1
Barreto-Medeiros, JM; Barros, KM; Cabral-Filho, JE; Castro, FM; Deiró, TC; Jesus-Deiró, RA; Manhães-de-Castro, R; Marinho, SM; Souza, SL; Toscano, AE1
Abbate-Daga, G; Brustolin, A; Campisi, S; Fassino, S; Leombruni, P; Levi, M; Marozio, S; Mondelli, V; Pierò, A1
Allison, KC; Etemad, B; Heo, M; Lundgren, JD; Martino, NS; O'Reardon, JP; Stunkard, AJ1
Al-Noori, S; Daumen, W; Figlewicz, DP; Sanders, NM; Taborsky, GJ; Wilkinson, CW; Zavosh, A1
Amato, G; Calzà, L; Giardino, L; Velardo, A; Zanni, M1
Briggs, SJ; Christopher, NC; Levin, ED; Rose, JE1
Abuzzahab, FS; Amin, M; Claghorn, JL; Dubé, S; Fabre, LF; Mendels, J; Petrie, WM; Small, JG1
Bartlett, SJ; Foster, GD; Greenstein, RA; Letizia, KA; Stunkard, AJ; Wadden, TA; Wingate, BJ1
Ruiz, P; Small, DR; Varner, RV1
Davies, TS; Kluwe, WM1
Kalia, M; Kramer, M; Miller, DB; O'Callaghan, JP1
Frank, GK; Kaye, WH; Marcus, MD1
Bal, C; Erol, M; Sahin, G; Yalcin, AU1
Fischette, CT; Reith, ME1
Claghorn, JL; Cohn, CK; Cohn, JB; Dessain, EC; Fabre, LF; Itil, TM; Lautin, A; Mendels, J; Shrivastava, R1
Heym, J; Koe, BK1

Reviews

1 review(s) available for sertraline and Body Weight

ArticleYear
Pharmacology of sertraline: a review.
    The Journal of clinical psychiatry, 1988, Volume: 49 Suppl

    Topics: 1-Naphthylamine; Animals; Behavior, Animal; Body Weight; Depressive Disorder; Humans; Naphthalenes; Obsessive-Compulsive Disorder; Rats; Serotonin Antagonists; Sertraline

1988

Trials

10 trial(s) available for sertraline and Body Weight

ArticleYear
A gender analysis of the study of pharmacotherapy of psychotic depression (STOP-PD): gender and age as predictors of response and treatment-associated changes in body mass index and metabolic measures.
    The Journal of clinical psychiatry, 2013, Volume: 74, Issue:10

    Topics: Adult; Age Factors; Aged; Antipsychotic Agents; Benzodiazepines; Body Mass Index; Body Weight; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Monitoring; Drug Therapy, Combination; Female; Hallucinations; Humans; Male; Metabolism; Middle Aged; Olanzapine; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Sertraline; Sex Factors; Socioeconomic Factors; Treatment Outcome

2013
Pharmacokinetics of sertraline across pregnancy and postpartum.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:6

    Topics: 1-Naphthylamine; Adult; Body Weight; Depressive Disorder, Major; Female; Humans; Longitudinal Studies; Postpartum Period; Pregnancy; Pregnancy Complications; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Selective Serotonin Reuptake Inhibitors; Sertraline; Young Adult

2008
Effect of pharmacological treatment of depression on A1C and quality of life in low-income Hispanics and African Americans with diabetes: a randomized, double-blind, placebo-controlled trial.
    Diabetes care, 2009, Volume: 32, Issue:12

    Topics: Antidepressive Agents; Anxiety; Black People; Blood Pressure; Body Weight; Cholesterol, LDL; Depression; Diabetes Complications; Double-Blind Method; Female; Glycated Hemoglobin; Hispanic or Latino; Humans; Male; Placebos; Predictive Value of Tests; Quality of Life; Sertraline; Sexual Behavior; Surveys and Questionnaires

2009
Multivariate therapeutic approach to binge-eating disorder: combined nutritional, psychological and pharmacological treatment.
    International clinical psychopharmacology, 2009, Volume: 24, Issue:6

    Topics: Anti-Obesity Agents; Binge-Eating Disorder; Body Weight; Cognitive Behavioral Therapy; Combined Modality Therapy; Counseling; Diet, Reducing; Female; Fructose; Humans; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline; Topiramate

2009
Glycemic control improvement through treatment of depression using antidepressant drugs in patients with diabetes mellitus type 1.
    Neuro endocrinology letters, 2010, Volume: 31, Issue:6

    Topics: Adult; Antidepressive Agents; Anxiety; Blood Glucose; Blood Pressure; Body Weight; Depression; Diabetes Mellitus, Type 1; Double-Blind Method; Female; Glycated Hemoglobin; Humans; Insulin; Male; Sertraline; Treatment Outcome

2010
A 12 to 24 weeks pilot study of sertraline treatment in obese women binge eaters.
    Human psychopharmacology, 2006, Volume: 21, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Body Mass Index; Body Weight; Bulimia Nervosa; Female; Humans; Middle Aged; Obesity; Personality Inventory; Pilot Projects; Selective Serotonin Reuptake Inhibitors; Sertraline; Severity of Illness Index; Survival Analysis; Time Factors

2006
Sertraline safety and efficacy in major depression: a double-blind fixed-dose comparison with placebo.
    Biological psychiatry, 1995, Nov-01, Volume: 38, Issue:9

    Topics: 1-Naphthylamine; Adolescent; Adult; Aged; Analysis of Variance; Antidepressive Agents; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Nausea; Sertraline; Treatment Outcome; Tremor

1995
Sertraline and relapse prevention training following treatment by very-low-calorie diet: a controlled clinical trial.
    Obesity research, 1995, Volume: 3, Issue:6

    Topics: 1-Naphthylamine; Adult; Affect; Analysis of Variance; Basal Metabolism; Body Mass Index; Body Weight; Diet, Reducing; Energy Intake; Female; Humans; Hunger; Middle Aged; Obesity; Patient Education as Topic; Recurrence; Selective Serotonin Reuptake Inhibitors; Sertraline; Treatment Outcome

1995
Sertraline hydrochloride treatment for patients with hemodialysis hypotension.
    Blood purification, 2002, Volume: 20, Issue:2

    Topics: Blood Pressure; Body Weight; Female; Humans; Hypotension; Kidney Failure, Chronic; Male; Middle Aged; Pilot Projects; Prospective Studies; Renal Dialysis; Sertraline

2002
Double-blind, multicenter comparison of sertraline and amitriptyline in elderly depressed patients.
    The Journal of clinical psychiatry, 1990, Volume: 51 Suppl B

    Topics: 1-Naphthylamine; Aged; Aged, 80 and over; Amitriptyline; Body Weight; Depressive Disorder; Drug Therapy, Combination; Female; Heart Rate; Humans; Male; Personality Inventory; Psychiatric Status Rating Scales; Pulse; Serotonin Antagonists; Sertraline

1990

Other Studies

21 other study(ies) available for sertraline and Body Weight

ArticleYear
Association between CYP metabolizer phenotypes and selective serotonin reuptake inhibitors induced weight gain: a retrospective cohort study.
    BMC medicine, 2022, 07-26, Volume: 20, Issue:1

    Topics: Body Weight; Citalopram; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 Enzyme System; Fluoxetine; Humans; Paroxetine; Phenotype; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Weight Gain

2022
Prenatal exposure to sertraline, associated or not with stress, can negatively program somatic and neurobehavioral development of female rats, and dysregulate reproductive function in adulthood.
    Reproductive toxicology (Elmsford, N.Y.), 2023, Volume: 116

    Topics: Animals; Body Weight; Female; Humans; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Reproduction; Sertraline

2023
Is lactational sertraline exposure safe for maternal health and the reproductive/neurobehavioral development of the descendants? A study in rats.
    Reproductive toxicology (Elmsford, N.Y.), 2023, Volume: 117

    Topics: Animals; Body Weight; Female; Humans; Lactation; Male; Maternal Exposure; Maternal Health; Prenatal Exposure Delayed Effects; Rats; Semen; Sertraline; Sexual Maturation

2023
Treatment with high-dose antidepressants severely exacerbates the pathological outcome of experimental Escherichia coli infections in poultry.
    PloS one, 2017, Volume: 12, Issue:10

    Topics: Animals; Antidepressive Agents; Body Weight; Chickens; Colony Count, Microbial; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Escherichia coli; Escherichia coli Infections; Fallopian Tubes; Female; Immunohistochemistry; Liver; Poultry Diseases; Sertraline; Tetracycline

2017
Stabilization treatment of remitted psychotic depression: the STOP-PD study.
    Acta psychiatrica Scandinavica, 2018, Volume: 138, Issue:3

    Topics: Adult; Aged; Antidepressive Agents; Antipsychotic Agents; Blood Glucose; Body Weight; Cholesterol; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Olanzapine; Placebos; Psychotic Disorders; Remission Induction; Sertraline; Triglycerides

2018
Antidepressant-like effect of n-3 PUFAs in CUMS rats: role of tPA/PAI-1 system.
    Physiology & behavior, 2015, Volume: 139

    Topics: Animals; Antidepressive Agents; Body Weight; Brain-Derived Neurotrophic Factor; Chronic Disease; Depressive Disorder; Disease Models, Animal; Fatty Acids, Omega-3; Hippocampus; Plasminogen Activator Inhibitor 1; Prefrontal Cortex; Random Allocation; Rats, Sprague-Dawley; Sertraline; Stress, Psychological; Tissue Plasminogen Activator

2015
Effects of Long-Term Treatment with Estradiol and Estrogen Receptor Subtype Agonists on Serotonergic Function in Ovariectomized Rats.
    Neuroendocrinology, 2016, Volume: 103, Issue:3-4

    Topics: Animals; Body Weight; Drug Delivery Systems; Enzyme Inhibitors; Estradiol; Estrogens; Fallopian Tubes; Female; Freezing Reaction, Cataleptic; Hippocampus; Oncogene Protein v-akt; Ovariectomy; Rats; Rats, Sprague-Dawley; Receptor, trkB; Selective Serotonin Reuptake Inhibitors; Serotonin; Sertraline; Signal Transduction; Swimming

2016
Sertraline inhibits increases in body fat and carbohydrate dysregulation in adult female cynomolgus monkeys.
    Psychoneuroendocrinology, 2016, Volume: 68

    Topics: Adipose Tissue; Animals; Antidepressive Agents; Body Composition; Body Weight; Carbohydrate Metabolism; Depression; Drug Administration Schedule; Female; Insulin; Longitudinal Studies; Macaca fascicularis; Models, Animal; Random Allocation; Selective Serotonin Reuptake Inhibitors; Sertraline

2016
Unusual weight fluctuation under corticosteroid and psychotropic treatment.
    Psychiatry and clinical neurosciences, 2008, Volume: 62, Issue:5

    Topics: Adult; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Appetite; Aripiprazole; Body Weight; Cyclosporine; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Eating; Female; Humans; Mianserin; Paroxetine; Piperazines; Prednisolone; Quinolones; Sertraline; Takayasu Arteritis

2008
Possible role of sertraline against 3-nitropropionic acid induced behavioral, oxidative stress and mitochondrial dysfunctions in rat brain.
    Progress in neuro-psychopharmacology & biological psychiatry, 2009, Feb-01, Volume: 33, Issue:1

    Topics: Animals; Antioxidants; Body Weight; Brain; Cerebral Cortex; Corpus Striatum; Hippocampus; Male; Mitochondria; Motor Activity; Nitro Compounds; Oxidative Stress; Propionates; Rats; Rats, Wistar; Reactive Oxygen Species; Rotarod Performance Test; Sertraline; Yohimbine

2009
Sertraline and its iodine product: experimental and theoretical vibrational studies: potential in vitro anti-thyroid activity of sertraline and iodine product toxicity with respect to male Wistar rats.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2013, Volume: 104

    Topics: Animals; Antithyroid Agents; Body Weight; Electrons; Iodine; Male; Molecular Conformation; Rats; Rats, Wistar; Sertraline; Solutions; Spectrophotometry, Ultraviolet; Spectroscopy, Fourier Transform Infrared; Swimming; Vibration

2013
Sertraline delays the somatic growth and reflex ontogeny in neonate rats.
    Physiology & behavior, 2006, Feb-28, Volume: 87, Issue:2

    Topics: Animals; Animals, Newborn; Animals, Suckling; Body Weight; Growth; Male; Rats; Rats, Wistar; Reflex; Selective Serotonin Reuptake Inhibitors; Sertraline

2006
A paradigm for facilitating pharmacotherapy at a distance: sertraline treatment of the night eating syndrome.
    The Journal of clinical psychiatry, 2006, Volume: 67, Issue:10

    Topics: Body Weight; Bulimia; Circadian Rhythm; Eating; Electronic Mail; Feeding and Eating Disorders; Humans; Hyperphagia; Internet; Interviews as Topic; Obesity; Personality Inventory; Remote Consultation; Selective Serotonin Reuptake Inhibitors; Sertraline; Sleep Initiation and Maintenance Disorders; Surveys and Questionnaires; Treatment Outcome

2006
The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia.
    American journal of physiology. Endocrinology and metabolism, 2008, Volume: 294, Issue:5

    Topics: Adrenocorticotropic Hormone; Animals; Autonomic Nervous System; Blood Glucose; Body Weight; Corticosterone; Eating; Epinephrine; Glucagon; Hypoglycemia; Male; Neurosecretory Systems; Norepinephrine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Stimulation, Chemical

2008
Effect of sertraline treatment on benzodiazepine receptors in the rat brain.
    Journal of neural transmission. General section, 1993, Volume: 94, Issue:1

    Topics: 1-Naphthylamine; Animals; Anti-Anxiety Agents; Antidepressive Agents; Behavior, Animal; Body Weight; Brain Chemistry; Cerebral Cortex; Limbic System; Male; Olfactory Pathways; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Selective Serotonin Reuptake Inhibitors; Sertraline

1993
Sertraline attenuates hyperphagia in rats following nicotine withdrawal.
    Pharmacology, biochemistry, and behavior, 1993, Volume: 44, Issue:1

    Topics: 1-Naphthylamine; Animals; Body Weight; Dose-Response Relationship, Drug; Drinking Behavior; Eating; Female; Nicotine; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Sertraline; Substance Withdrawal Syndrome

1993
Black and white patients response to antidepressant treatment for major depression.
    The Psychiatric quarterly, 1998,Summer, Volume: 69, Issue:2

    Topics: 1-Naphthylamine; Adult; Ambulatory Care; Antidepressive Agents, Tricyclic; Black People; Body Weight; Depressive Disorder; Dose-Response Relationship, Drug; Female; Fluoxetine; Humans; Length of Stay; Male; Middle Aged; Pharmacogenetics; Psychiatric Status Rating Scales; Retrospective Studies; Selective Serotonin Reuptake Inhibitors; Sertraline; Sex Factors; Treatment Outcome; White People

1998
Preclinical toxicological evaluation of sertraline hydrochloride.
    Drug and chemical toxicology, 1998, Volume: 21, Issue:4

    Topics: Adenoma; Animals; Behavior, Animal; Body Weight; Dogs; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Embryo, Mammalian; Embryonic and Fetal Development; Female; Fertility; Lethal Dose 50; Liver; Liver Function Tests; Male; Mice; Muscle Weakness; Organ Size; Rabbits; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Sertraline; Toxicity Tests

1998
Comparative study of fluoxetine, sibutramine, sertraline and dexfenfluramine on the morphology of serotonergic nerve terminals using serotonin immunohistochemistry.
    Brain research, 2000, Mar-06, Volume: 858, Issue:1

    Topics: Animals; Appetite Depressants; Body Weight; Cyclobutanes; Dexfenfluramine; Eating; Fluoxetine; Immunohistochemistry; Male; N-Methyl-3,4-methylenedioxyamphetamine; Prefrontal Cortex; Presynaptic Terminals; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Agents; Serotonin Receptor Agonists; Sertraline

2000
Sertraline in underweight binge eating/purging-type eating disorders: five case reports.
    The International journal of eating disorders, 2001, Volume: 29, Issue:4

    Topics: Adolescent; Adult; Body Weight; Bulimia; Female; Humans; Selective Serotonin Reuptake Inhibitors; Sertraline

2001
Sertraline and cocaine-induced locomotion in mice. II. Chronic studies.
    Psychopharmacology, 1991, Volume: 103, Issue:3

    Topics: 1-Naphthylamine; Animals; Body Weight; Cocaine; Female; Mice; Mice, Inbred C57BL; Motor Activity; Serotonin Antagonists; Sertraline

1991